Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial
Françoise Kraeber-Bodéré, Alain Faivre-Chauvet, Ludovic Ferrer, et al.
Plos One
|
March 22, 2013
Calibration test of PET scanners in a multi-centre clinical trial on breast cancer therapy monitoring using 18F-FLT
Francis Bouchet, Lilli Geworski, Bernd O Knoop, et al.
Clinical Nuclear Medicine
|
June 24, 2024
Pilot Feasibility Study: 18 F-DPA-714 PET/CT Macrophage Imaging in Triple-Negative Breast Cancers (EITHICS)
Caroline Rousseau, Raphaël Metz, Olivier Kerdraon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2016
A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
Florence Magrangeas, Rowan Kuiper, Hervé Avet-Loiseau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 8, 2006
Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography
Caroline Rousseau, Anne Devillers, Christine Sagan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 26, 2023
Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study
Gunjan Kayal, Nathaly Barbosa, Carlos Calderón Marín, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 15, 2020
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Caroline Rousseau, David M Goldenberg, Mathilde Colombié, et al.
The Lancet. Haematology
|
December 22, 2015
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study
Patrice Chevallier, Thomas Eugene, Nelly Robillard, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial
Françoise Kraeber-Bodéré, Alain Faivre-Chauvet, Ludovic Ferrer, et al.
Plos One
|
March 22, 2013
Calibration test of PET scanners in a multi-centre clinical trial on breast cancer therapy monitoring using 18F-FLT
Francis Bouchet, Lilli Geworski, Bernd O Knoop, et al.
Clinical Nuclear Medicine
|
June 24, 2024
Pilot Feasibility Study: 18 F-DPA-714 PET/CT Macrophage Imaging in Triple-Negative Breast Cancers (EITHICS)
Caroline Rousseau, Raphaël Metz, Olivier Kerdraon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2016
A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
Florence Magrangeas, Rowan Kuiper, Hervé Avet-Loiseau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 8, 2006
Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography
Caroline Rousseau, Anne Devillers, Christine Sagan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 26, 2023
Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study
Gunjan Kayal, Nathaly Barbosa, Carlos Calderón Marín, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 15, 2020
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
Caroline Rousseau, David M Goldenberg, Mathilde Colombié, et al.
The Lancet. Haematology
|
December 22, 2015
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study
Patrice Chevallier, Thomas Eugene, Nelly Robillard, et al.
Page
of 6